Clinical Trial: Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

Sponsor and Collaborators
Astex Therapeutics
Multiple Myeloma Research Consortium.

ClinicalTrials.gov Identifier
NCT01183949


Continue Reading